Annual EBIT:
$49.62M+$23.95M(+93.25%)Summary
- As of today, TGTX annual earnings before interest & taxes is $49.62 million, with the most recent change of +$23.95 million (+93.25%) on December 31, 2024.
- During the last 3 years, TGTX annual EBIT has risen by +$392.08 million (+114.49%).
- TGTX annual EBIT is now at all-time high.
Performance
TGTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$37.64M+$25.41M(+207.86%)Summary
- As of today, TGTX quarterly earnings before interest & taxes is $37.64 million, with the most recent change of +$25.41 million (+207.86%) on June 30, 2025.
- Over the past year, TGTX quarterly EBIT has increased by +$27.11 million (+257.48%).
- TGTX quarterly EBIT is now -68.01% below its all-time high of $117.64 million, reached on September 30, 2023.
Performance
TGTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$97.47M+$27.11M(+38.52%)Summary
- As of today, TGTX TTM earnings before interest & taxes is $97.47 million, with the most recent change of +$27.11 million (+38.52%) on June 30, 2025.
- Over the past year, TGTX TTM EBIT has dropped by -$10.71 million (-9.90%).
- TGTX TTM EBIT is now -9.90% below its all-time high of $108.19 million, reached on June 30, 2024.
Performance
TGTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
TGTX EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +93.3% | +257.5% | -9.9% |
3Y3 Years | +114.5% | +200.4% | +134.7% |
5Y5 Years | +129.6% | +174.3% | +143.6% |
TGTX EBIT Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +114.5% | -68.0% | +149.8% | -9.9% | +142.3% |
5Y | 5-Year | at high | +114.5% | -68.0% | +140.8% | -9.9% | +128.5% |
All-Time | All-Time | at high | +114.5% | -68.0% | +140.8% | -9.9% | +128.5% |
TGTX EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $37.64M(+207.9%) | $97.47M(+38.5%) |
Mar 2025 | - | $12.22M(-62.4%) | $70.37M(+41.4%) |
Dec 2024 | $49.62M(+93.3%) | $32.51M(+115.3%) | $49.75M(+781.7%) |
Sep 2024 | - | $15.10M(+43.4%) | $5.64M(-94.8%) |
Jun 2024 | - | $10.53M(+225.5%) | $108.19M(+101.6%) |
Mar 2024 | - | -$8.39M(+27.6%) | $53.67M(+109.0%) |
Dec 2023 | $25.68M(+112.0%) | -$11.60M(-109.9%) | $25.68M(+167.0%) |
Sep 2023 | - | $117.64M(+367.5%) | -$38.34M(+79.8%) |
Jun 2023 | - | -$43.98M(-20.9%) | -$190.15M(-3.5%) |
Mar 2023 | - | -$36.39M(+51.9%) | -$183.66M(+14.0%) |
Dec 2022 | -$213.62M(+37.6%) | -$75.61M(-121.3%) | -$213.62M(+7.2%) |
Sep 2022 | - | -$34.17M(+8.9%) | -$230.27M(+18.0%) |
Jun 2022 | - | -$37.49M(+43.5%) | -$280.70M(+12.3%) |
Mar 2022 | - | -$66.35M(+28.1%) | -$320.08M(+6.5%) |
Dec 2021 | -$342.46M(-25.4%) | -$92.26M(-9.1%) | -$342.46M(-1.6%) |
Sep 2021 | - | -$84.60M(-10.1%) | -$337.13M(+0.3%) |
Jun 2021 | - | -$76.87M(+13.4%) | -$338.08M(-8.4%) |
Mar 2021 | - | -$88.73M(-2.1%) | -$311.87M(-14.2%) |
Dec 2020 | -$273.05M(-62.9%) | -$86.93M(-1.6%) | -$273.05M(-22.0%) |
Sep 2020 | - | -$85.55M(-68.9%) | -$223.80M(-12.7%) |
Jun 2020 | - | -$50.66M(-1.5%) | -$198.64M(-8.5%) |
Mar 2020 | - | -$49.91M(-32.5%) | -$183.12M(-9.3%) |
Dec 2019 | -$167.58M(+2.9%) | -$37.67M(+37.6%) | -$167.58M(+8.7%) |
Sep 2019 | - | -$60.39M(-71.9%) | -$183.55M(-17.0%) |
Jun 2019 | - | -$35.14M(-2.2%) | -$156.89M(+5.3%) |
Mar 2019 | - | -$34.38M(+35.9%) | -$165.67M(+4.2%) |
Dec 2018 | -$172.60M(-46.7%) | -$53.64M(-59.0%) | -$172.87M(-15.9%) |
Sep 2018 | - | -$33.73M(+23.2%) | -$149.18M(-1.5%) |
Jun 2018 | - | -$43.92M(-5.6%) | -$147.03M(-11.8%) |
Mar 2018 | - | -$41.58M(-38.8%) | -$131.54M(-11.8%) |
Dec 2017 | -$117.63M(-49.0%) | -$29.95M(+5.2%) | -$117.63M(-5.3%) |
Sep 2017 | - | -$31.59M(-11.1%) | -$111.70M(-6.3%) |
Jun 2017 | - | -$28.43M(-2.7%) | -$105.04M(-13.4%) |
Mar 2017 | - | -$27.67M(-15.1%) | -$92.64M(-17.3%) |
Dec 2016 | -$78.97M(-25.0%) | -$24.03M(+3.6%) | -$78.97M(-7.4%) |
Sep 2016 | - | -$24.93M(-55.6%) | -$73.52M(-18.6%) |
Jun 2016 | - | -$16.02M(-14.5%) | -$62.00M(+1.3%) |
Mar 2016 | - | -$13.99M(+24.7%) | -$62.83M(+0.6%) |
Dec 2015 | -$63.18M(-13.4%) | -$18.57M(-38.5%) | -$63.18M(+1.3%) |
Sep 2015 | - | -$13.41M(+20.5%) | -$64.04M(+5.6%) |
Jun 2015 | - | -$16.86M(-17.5%) | -$67.85M(-8.1%) |
Mar 2015 | - | -$14.34M(+26.2%) | -$62.74M(-12.6%) |
Dec 2014 | -$55.72M(-185.4%) | -$19.43M(-12.9%) | -$55.72M(-33.6%) |
Sep 2014 | - | -$17.22M(-46.5%) | -$41.71M(-44.8%) |
Jun 2014 | - | -$11.75M(-60.5%) | -$28.81M(-23.1%) |
Mar 2014 | - | -$7.32M(-35.0%) | -$23.40M(-19.9%) |
Dec 2013 | -$19.53M(+21.7%) | -$5.42M(-25.7%) | -$19.53M(-14.5%) |
Sep 2013 | - | -$4.32M(+32.0%) | -$17.05M(-12.1%) |
Jun 2013 | - | -$6.34M(-84.3%) | -$15.21M(-35.7%) |
Mar 2013 | - | -$3.44M(-17.0%) | -$11.21M(+55.1%) |
Dec 2012 | -$24.95M(-2728.5%) | -$2.94M(-18.6%) | -$24.95M(-10.6%) |
Sep 2012 | - | -$2.48M(-5.8%) | -$22.56M(-12.2%) |
Jun 2012 | - | -$2.35M(+86.3%) | -$20.11M(-11.3%) |
Mar 2012 | - | -$17.18M(-2995.4%) | -$18.06M(+5.7%) |
Dec 2011 | -$882.00K(+56.3%) | -$554.90K(-1743.5%) | -$19.15M(+12.2%) |
Sep 2011 | - | -$30.10K(+89.9%) | -$21.81M(-2.0%) |
Jun 2011 | - | -$297.00K(+98.4%) | -$21.39M(+1.1%) |
Mar 2011 | - | -$18.27M(-468.6%) | -$21.61M(-457.6%) |
Dec 2010 | -$2.02M | -$3.21M(-922.1%) | -$3.88M(-285.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2010 | - | $390.80K(+174.4%) | -$1.00M(+43.9%) |
Jun 2010 | - | -$525.10K(+0.8%) | -$1.79M(-2.7%) |
Mar 2010 | - | -$529.40K(-55.1%) | -$1.74M(+1.6%) |
Dec 2009 | -$1.77M(+59.9%) | -$341.30K(+13.7%) | -$1.77M(-28.6%) |
Sep 2009 | - | -$395.60K(+17.1%) | -$1.38M(+41.8%) |
Jun 2009 | - | -$477.30K(+14.4%) | -$2.37M(+29.5%) |
Mar 2009 | - | -$557.30K(-1165.6%) | -$3.36M(+23.9%) |
Dec 2008 | -$4.41M(+63.7%) | $52.30K(+103.8%) | -$4.41M(+30.9%) |
Sep 2008 | - | -$1.38M(+5.7%) | -$6.38M(+17.2%) |
Jun 2008 | - | -$1.47M(+9.1%) | -$7.71M(+31.0%) |
Mar 2008 | - | -$1.61M(+15.9%) | -$11.16M(+8.1%) |
Dec 2007 | -$12.14M(-21.4%) | -$1.92M(+29.1%) | -$12.14M(+9.4%) |
Sep 2007 | - | -$2.71M(+45.0%) | -$13.41M(-5.9%) |
Jun 2007 | - | -$4.92M(-89.8%) | -$12.66M(-25.4%) |
Mar 2007 | - | -$2.59M(+18.4%) | -$10.10M(-1.0%) |
Dec 2006 | -$10.00M(+48.3%) | -$3.18M(-61.8%) | -$10.00M(+53.2%) |
Sep 2006 | - | -$1.97M(+16.6%) | -$21.35M(-0.5%) |
Jun 2006 | - | -$2.36M(+5.6%) | -$21.24M(-4.2%) |
Mar 2006 | - | -$2.50M(+82.8%) | -$20.40M(-5.4%) |
Dec 2005 | -$19.36M(-215.1%) | -$14.53M(-680.4%) | -$19.36M(-192.3%) |
Sep 2005 | - | -$1.86M(-23.3%) | -$6.62M(+5.4%) |
Jun 2005 | - | -$1.51M(-3.6%) | -$7.00M(-8.1%) |
Mar 2005 | - | -$1.46M(+18.7%) | -$6.48M(-5.5%) |
Dec 2004 | -$6.14M(-29.1%) | -$1.79M(+20.1%) | -$6.14M(-4.6%) |
Sep 2004 | - | -$2.24M(-127.2%) | -$5.87M(-3.6%) |
Jun 2004 | - | -$986.70K(+12.1%) | -$5.67M(-3.8%) |
Mar 2004 | - | -$1.12M(+26.2%) | -$5.46M(-14.7%) |
Dec 2003 | -$4.76M(-367.3%) | -$1.52M(+25.4%) | -$4.76M(-55.0%) |
Sep 2003 | - | -$2.04M(-162.4%) | -$3.07M(-89.6%) |
Jun 2003 | - | -$777.00K(-84.0%) | -$1.62M(-48.4%) |
Mar 2003 | - | -$422.20K(-350.9%) | -$1.09M(+16.0%) |
Dec 2002 | -$1.02M(+67.2%) | $168.30K(+128.6%) | -$1.30M(+35.9%) |
Sep 2002 | - | -$588.20K(-136.4%) | -$2.02M(+5.4%) |
Jun 2002 | - | -$248.80K(+60.5%) | -$2.14M(+36.4%) |
Mar 2002 | - | -$629.60K(-12.8%) | -$3.37M(-13.7%) |
Dec 2001 | -$3.11M(+1.7%) | -$558.20K(+20.8%) | -$2.96M(-3382.8%) |
Sep 2001 | - | -$704.50K(+52.2%) | -$85.00K(+75.3%) |
Jun 2001 | - | -$1.47M(-556.6%) | -$344.00K(+82.5%) |
Mar 2001 | - | -$224.40K(-109.7%) | -$1.97M(+37.4%) |
Dec 2000 | -$3.16M(-17.1%) | $2.32M(+340.5%) | -$3.15M(+48.1%) |
Sep 2000 | - | -$963.50K(+68.9%) | -$6.06M(-8.3%) |
Jun 2000 | - | -$3.10M(-120.8%) | -$5.60M(-74.9%) |
Mar 2000 | - | -$1.40M(-133.8%) | -$3.20M(-14.4%) |
Dec 1999 | -$2.70M(+15.6%) | -$600.00K(-20.0%) | -$2.80M(+22.2%) |
Sep 1999 | - | -$500.00K(+28.6%) | -$3.60M(+16.3%) |
Jun 1999 | - | -$700.00K(+30.0%) | -$4.30M(-53.6%) |
Mar 1999 | - | -$1.00M(+28.6%) | -$2.80M(+9.7%) |
Dec 1998 | -$3.20M(+39.6%) | -$1.40M(-16.7%) | -$3.10M(+6.1%) |
Sep 1998 | - | -$1.20M(-250.0%) | -$3.30M(-6.5%) |
Jun 1998 | - | $800.00K(+161.5%) | -$3.10M(+44.6%) |
Mar 1998 | - | -$1.30M(+18.8%) | -$5.60M(-9.8%) |
Dec 1997 | -$5.30M(-43.2%) | -$1.60M(-60.0%) | -$5.10M(-10.9%) |
Sep 1997 | - | -$1.00M(+41.2%) | -$4.60M(+2.1%) |
Jun 1997 | - | -$1.70M(-112.5%) | -$4.70M(-30.6%) |
Mar 1997 | - | -$800.00K(+27.3%) | -$3.60M(-33.3%) |
Dec 1996 | -$3.70M | -$1.10M(0.0%) | -$2.70M(-68.8%) |
Sep 1996 | - | -$1.10M(-83.3%) | -$1.60M(-220.0%) |
Jun 1996 | - | -$600.00K(-700.0%) | -$500.00K(-600.0%) |
Mar 1996 | - | $100.00K | $100.00K |
FAQ
- What is TG Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. annual EBIT year-on-year change?
- What is TG Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is TG Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. TTM EBIT year-on-year change?
What is TG Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of TGTX is $49.62M
What is the all-time high annual EBIT for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high annual earnings before interest & taxes is $49.62M
What is TG Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, TGTX annual earnings before interest & taxes has changed by +$23.95M (+93.25%)
What is TG Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of TGTX is $37.64M
What is the all-time high quarterly EBIT for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $117.64M
What is TG Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, TGTX quarterly earnings before interest & taxes has changed by +$27.11M (+257.48%)
What is TG Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of TGTX is $97.47M
What is the all-time high TTM EBIT for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $108.19M
What is TG Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, TGTX TTM earnings before interest & taxes has changed by -$10.71M (-9.90%)